# Novo's Awiqli® receives FDA approval as the first and only once-weekly insulin for children 10 years of age and older with type 2 diabetes

- Source: PR Newswire
- Published: 2026-10-23T18:21:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/novos-awiqli-receives-fda-approval-as-the-first-and-only-once-weekly-insulin-for-children-10-years-of-age-and-older-with-type-2-diabetes-302918384.html
- Canonical: https://groundlevelnews.com/story/novo-s-awiqli-receives-fda-approval-as-the-first-and-only-once-weekly--c1edfe/

Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to one1 As type 2 diabetes incidence rates among youth continue to rise,² Awiqli® may help reduce administration barriers associated with daily...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._